Deepali Dixit

977 total citations
41 papers, 467 citations indexed

About

Deepali Dixit is a scholar working on Critical Care and Intensive Care Medicine, Pulmonary and Respiratory Medicine and Cardiology and Cardiovascular Medicine. According to data from OpenAlex, Deepali Dixit has authored 41 papers receiving a total of 467 indexed citations (citations by other indexed papers that have themselves been cited), including 17 papers in Critical Care and Intensive Care Medicine, 8 papers in Pulmonary and Respiratory Medicine and 6 papers in Cardiology and Cardiovascular Medicine. Recurrent topics in Deepali Dixit's work include Intensive Care Unit Cognitive Disorders (12 papers), Antibiotic Use and Resistance (6 papers) and Anesthesia and Sedative Agents (6 papers). Deepali Dixit is often cited by papers focused on Intensive Care Unit Cognitive Disorders (12 papers), Antibiotic Use and Resistance (6 papers) and Anesthesia and Sedative Agents (6 papers). Deepali Dixit collaborates with scholars based in United States, United Kingdom and Australia. Deepali Dixit's co-authors include Mary Barna Bridgeman, Prabhakar Kumar Verma, Rakesh Kumar Marwaha, Elizabeth S. John, Sita Chokhavatia, Siu Yan Amy Yeung, Sandeep Devabhakthuni, Lisa Burry, Tanaya Bhowmick and Navaneeth Narayanan and has published in prestigious journals such as SHILAP Revista de lepidopterología, Clinical Infectious Diseases and CHEST Journal.

In The Last Decade

Deepali Dixit

36 papers receiving 454 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Deepali Dixit United States 12 129 93 62 56 56 41 467
Nagarajan Ramakrishnan India 15 114 0.9× 116 1.2× 190 3.1× 18 0.3× 59 1.1× 56 757
Riccardo Pinciroli United States 15 267 2.1× 236 2.5× 74 1.2× 29 0.5× 9 0.2× 34 522
Thomas Kander Sweden 14 110 0.9× 211 2.3× 130 2.1× 32 0.6× 11 0.2× 70 620
Javier Gómez‐Pavón Spain 15 43 0.3× 52 0.6× 66 1.1× 92 1.6× 21 0.4× 74 645
Pascal L. Langlois Canada 14 178 1.4× 158 1.7× 84 1.4× 45 0.8× 34 0.6× 28 814
Kacper Lechowicz Poland 10 106 0.8× 56 0.6× 29 0.5× 166 3.0× 25 0.4× 14 677
Jiannong Wu China 12 101 0.8× 65 0.7× 145 2.3× 27 0.5× 10 0.2× 30 632
Victoria C. Ziesenitz Germany 12 93 0.7× 32 0.3× 87 1.4× 20 0.4× 10 0.2× 38 640
Sylwester Drożdżal Poland 10 105 0.8× 44 0.5× 28 0.5× 163 2.9× 25 0.4× 13 671
Bradley Power Australia 12 73 0.6× 69 0.7× 92 1.5× 24 0.4× 10 0.2× 22 758

Countries citing papers authored by Deepali Dixit

Since Specialization
Citations

This map shows the geographic impact of Deepali Dixit's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Deepali Dixit with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Deepali Dixit more than expected).

Fields of papers citing papers by Deepali Dixit

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Deepali Dixit. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Deepali Dixit. The network helps show where Deepali Dixit may publish in the future.

Co-authorship network of co-authors of Deepali Dixit

This figure shows the co-authorship network connecting the top 25 collaborators of Deepali Dixit. A scholar is included among the top collaborators of Deepali Dixit based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Deepali Dixit. Deepali Dixit is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
2.
Jagpal, Sugeet, et al.. (2024). Correction of Electrolyte Abnormalities in Critically Ill Patients. SHILAP Revista de lepidopterología. 4(1). 19–37. 7 indexed citations
3.
Betthauser, Kevin D., Deepali Dixit, Christine M. Groth, et al.. (2024). Effect of Inpatient Pharmacist-Led Medication Reconciliations on Medication-Related Interventions in Intensive Care Unit Recovery Centers. Hospital Pharmacy. 59(6). 650–659.
4.
Smith, Zachary, et al.. (2024). Critical care pharmacist perspectives on optimal practice models and prioritization of professional activities: A cross-sectional survey. American Journal of Health-System Pharmacy. 81(24). 1267–1277. 1 indexed citations
5.
Azim, Ahmed Abdul, et al.. (2023). Rapid Diagnostics to Enhance Therapy Selection for the Treatment of Bacterial Infections. Current Pharmacology Reports. 9(4). 198–216. 7 indexed citations
7.
Pogue, Jason M., et al.. (2023). Executive Summary: State-of-the-Art Review: State of the Management of Infections Caused by Multidrug-Resistant Gram-Negative Organisms. Clinical Infectious Diseases. 77(9). 1223–1225. 2 indexed citations
8.
Pogue, Jason M., et al.. (2023). State of the Management of Infections Caused by Multidrug-Resistant Gram-Negative Organisms. Clinical Infectious Diseases. 77(9). e46–e56. 4 indexed citations
9.
Adams, Christopher, et al.. (2021). Implementation and evaluation of a virtual learning advanced pharmacy practice experience. Currents in Pharmacy Teaching and Learning. 13(7). 862–867. 8 indexed citations
10.
Adams, Christopher, Jerry Altshuler, Karen Berger, et al.. (2021). Corticosteroid use in ARDS and its application to evolving therapeutics for coronavirus disease 2019 (COVID‐19): A systematic review. Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy. 42(1). 71–90. 15 indexed citations
11.
Sharma, Roopali, et al.. (2021). Managing toxicities associated with immune checkpoint inhibitors. JAAPA. 34(6). 32–39. 5 indexed citations
12.
Barlow, Brooke, Ashley Barlow, Melissa L. Thompson Bastin, et al.. (2020). Minimizing pharmacotherapy-related healthcare worker exposure to SARS-CoV-2. American Journal of Health-System Pharmacy. 77(18). 1529–1531. 1 indexed citations
13.
Hogan, Michael, et al.. (2018). Effectiveness of empiric aztreonam compared to other beta-lactams for treatment of <em>Pseudomonas aeruginosa</em> infections. Infection and Drug Resistance. Volume 11. 1975–1981. 6 indexed citations
14.
15.
Dixit, Deepali, et al.. (2018). Stevens-Johnson Syndrome Associated With Chlordiazepoxide. Journal of Pharmacy Technology. 34(2). 82–85. 5 indexed citations
16.
Bhowmick, Tanaya, et al.. (2017). Recommendations From the 2016 Guidelines for the Management of Adults With Hospital-Acquired or Ventilator-Associated Pneumonia.. PubMed. 42(12). 767–772. 24 indexed citations
17.
Chokhavatia, Sita, Elizabeth S. John, Mary Barna Bridgeman, & Deepali Dixit. (2016). Constipation in Elderly Patients with Noncancer Pain: Focus on Opioid-Induced Constipation. Drugs & Aging. 33(8). 557–574. 39 indexed citations
18.
Dixit, Deepali, et al.. (2016). Management of Acute Alcohol Withdrawal Syndrome in Critically Ill Patients. Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy. 36(7). 797–822. 69 indexed citations
19.
Dixit, Deepali, et al.. (2015). Pharmacologic management of chronic stable angina. JAAPA. 28(6). 1–8. 4 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026